News Center

Home page

Peak Report

News reports

Experience of year-end chat in Jinhua, a pharmaceutical sales company

Release time:

2021-01-21

Pharmaceutical Sales Company Jinhua Office Year-end Chat Experience

Editor's Note:# At the end of the year and the beginning of the year, the Jinhua Office of Pharmaceutical Sales Company organized the salesman to write an annual summary, talk about one year's work and share experiences. This newspaper has excerpted some of them.

Chen Yanguo

Looking back on the past year, I couldn't help feeling deeply touched. There was no vigorous success, but it was also an extraordinary test and sharpening.

2020

was a tough year, from the beginning of the year when the Paroxetine national collection dropped the mark, the new crown epidemic caused the work not to be carried out well until the second quarter to really get to work. However, 2020 is also a brilliant year. My Jinhua Office has completed all sales tasks with everyone's efforts. My personal sales have also increased compared with last year.

Sales is actually a process, including preparation before the visit, visit, and follow-up after the visit. The work of our medical representatives is not like ordinary sales. After the first sales transaction, we have to achieve long-term cooperation, from the first drug to the second-line drug, conventional drug or even recommended drug. Therefore, the follow-up work after our visit has become the focus of our daily work. I feel that in the future follow-up, I should focus on strengthening friendship and building trust, and strive to establish a lasting partnership. Timely follow-up, uninterrupted follow-up visits, let the doctor feel their dedication and respect for him.

At the same time, as a medical representative, we are dealing with highly educated doctors with extensive clinical experience. Therefore, we must continue to learn, improve our professionalism, and create a peer-to-peer platform to communicate with customers.

Shao Junli

Time passed quickly. In a twinkling of an eye, 2020 has passed. In this year, with the support and help of the company's leaders and office managers, combined with my own efforts, I have achieved relatively good results in my work.

I would like to mention again the work done when olopatadine eye drops entered Lanxi Hospital of Traditional Chinese Medicine. Olopatadine Eye Drops is a product for the treatment of allergic conjunctivitis and a blockbuster product of the Pharmaceutical Company in 2020. In July, I greeted the ophthalmologist of the hospital and hoped to help make a report. Because the company's glass eye has been sold in the hospital of traditional Chinese medicine, all the doctors in the ophthalmology department and I have kept visiting frequently, and everyone has great trust in our company's products. At the end of September, Olo was able to enter the hospital. I went to the director of the pharmacy building and showed her our product brochure to tell her the advantages of our products, but the director of the pharmacy department rejected it on the grounds that the price was too high and was unable to enter the hospital. However, I did not give up. Through repeated efforts, the director of the building was finally moved by my sincerity and agreed to go to Tseolo. After a month and a half, I finally successfully developed Olo into Lanxi Hospital of Traditional Chinese Medicine. After this incident, I also realized that as long as the effort is deep, any difficulty can be overcome, and we must have the spirit of perseverance to do a thing successfully.

In the face of the increase or decrease of the national collection and medical insurance catalogue, we medical personnel have gone through tests again and again, but we must face the difficulties. Because we always have to face the difficulties first before we can ride the waves later. We will certainly be able to break through the difficulties, through the winter, ushered in the spring. Looking forward to better 2021.

Zhou Yanqiu

2020

is fleeting. Looking back on this year's work, there are both melancholy and fruitful joy.

2020

is a special year, the new crown epidemic caused by the sudden decline in the foreign population, Yiwu at the beginning of the product catalog adjustment, with volume procurement, three major reasons to the market has brought a considerable impact. I'm a little overwhelmed by the marked decline in market sales. We can't do anything about natural disasters and policies, but the task still needs to be completed. What should we do?

Through communication with leaders and discussions among colleagues, we finally feel that only by refining the existing market and developing new markets can we increase sales. Large hospitals will develop departments that can be used in place, health centers will lay out all the following service stations in place, and newly developed customers will be trained quietly to become VIP. At the same time to develop ophthalmology, increase the sales of new products, walk on two legs, take every step seriously.

Sales is a good training in life. If you want to do a good job in sales, I personally think you must have a high comprehensive ability and learning ability. At ordinary times, we should be diligent in thinking about working methods and skills and expand our thinking. We should be optimistic and positive to face the problems in our work. Work enthusiastically.

2020

has passed, and the 2021 is coming soon. The new year has a new goal. As long as we work hard and focus on optimism, I believe the sales volume will definitely get better and better.

Xu Zihan

sales work, both ups and downs, thank the company very much, let me get exercise in recent years.

The most important thing is to learn carefully and serve customers attentively. When visiting the hospital, I will pay more attention to observation. Sometimes I find that they often look everywhere for the same thing. I will help take it there next time. This is a trivial matter for me. When I think about it, I will do it. However, the teachers in the hospital will think that I am very careful and trustworthy. At ordinary times, I will send more messages to customers when I am free. Some words cannot be expressed in words. It will be better to express them in words. Holiday greetings and a message may have unexpected results. Just like Christmas, I sent a message to all my customers. Although only 30% of them gave me a message back, I was satisfied.

In the past few years of work, I have experienced losses, regrets, and gains and enrichment... For the new year, I still have dreams in my heart. If the policy allows, Les has to be able to Get better and better, and other products can be made slowly. In the new year, I hope that with the support of the leadership, we can go to the next level, not be at a loss for the current difficulties, and believe that our efforts can create a brilliant tomorrow.

Zheng Jie

Looking back on 2020, I experienced epidemic situation, drug withdrawal, limited amount and other events, and I felt a lot of emotion in my heart.

In particular, the implementation of amlodipine band procurement in 2020, under the impact of the primary completion of hospitals with similar varieties of band volume, coupled with the new crown epidemic led to the national home epidemic prevention, the sales of Rest has dropped sharply, and some hospitals even stopped the procurement of Rest first. However, I still maintain a high frequency of contact with customers, learned that they are in the front line of the epidemic, a mask to use two days, I began to trust various relationships to buy masks, masks sent to the hands of doctors, to do something to fight the epidemic. When doctors received masks, they laughed and said they were the most useful gift in life. I also participated in the volunteer service of the hospital, and went door-to-door with them to fill in the personnel information form. Through such efforts, I finally got the praise of the hospital leaders and restored the prescription of Ristek.

June is the time to fill in the volunteer form for the college entrance examination. The hospital I maintain has 12 doctors' children who need to fill in the volunteer form. Usually, I pay more attention to the details of voluntary reporting. When I provide them with accurate and reasonable suggestions, I suddenly become their voluntary reporting consultant. I used the rest time to communicate with the examinees. According to their thoughts, learning ability and personality, I constantly revised dozens of filling plans. From the choice of school and major to the ranking of school volunteers, I gave reasonable suggestions. When their children received the admission notice of their favorite school, the trust of customers in me increased to a higher level, at the same time, it also completed the conversion from business to friends, to enhance their loyalty to the company's varieties. First of all, do a good job of people and get their recognition, and they will transfer this recognition to the product, which will turn into support for my work.

More information

Two Cement Enterprises Prosperous Production and Sales in May

With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.

2020

07-31

The company's "safe production month" activities are about to start

June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-30

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-22

The 14th meeting of the 10th board of directors and the 9th meeting of the 9th board of supervisors held to review and approve the annual work report and other relevant proposals

On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.

2020

07-31

< 1...23 24 25...61 > 跳转到页